Evaluation of Enzyme Immunoassay using a Recombinant Envelope Protein Expressed in Insect Cells for Serological Confirmation of HTLV-I Infection

Kazuyo Yamashita*, Midori Maekawa, Kohnosuke Mitani, Maki Wakamiya, Toshio Ogino, Kikuko Miyamura, Koichi Baba, Yoshiko Yamamoto, Hiroshi Nyunoya, Kunitada Shimotohno, Yutaka Takebe, Shudo Yamazaki

*この研究の対応する著者

研究成果: Article査読

1 被引用数 (Scopus)

抄録

A recombinant human T-lymphotropic virus type I (HTLV-I) envelope protein expressed in insect cells using a recombinant baculovirus was employed as the antigen in an enzyme immunoassay (renvEIA). Peripheral blood samples were obtained from asymptomatic carriers or healthy individuals. Plasma was tested for HTLV-I antibody by renvEIA, particle agglutination, and Western immunoblot (WB), and lymphocyte DNA was tested for HTLV-I proviral DNA amplification by polymerase chain reaction (PCR). Of 61 people aged 9 months or older, 23 were positive (gag+, env+) and 19 others were in the “indeterminate” category (gag+, env-) when their WB results were interpreted according to the WHO-proposed criteria. Thirty-seven cases, including all of the WB+ cases and 14 of 19 WB indeterminate cases, were positive by renvEIA. In 34 of 37 renvEIA-positive cases, the presence of long terminal repeat (LTR) and tax/rex region of HTLV-I proviral DNA was detected by polymerase chain reaction (PCR) and following Southern blot hybridization. Thus, renvEIA would be a useful supplemental assay to confirm the presence of HTLV-I antibody in HTLV-I asymptomatic carriers.

本文言語English
ページ(範囲)1857-1861
ページ数5
ジャーナルAIDS Research and Human Retroviruses
8
11
DOI
出版ステータスPublished - 1992 11月
外部発表はい

ASJC Scopus subject areas

  • 免疫学
  • ウイルス学
  • 感染症

フィンガープリント

「Evaluation of Enzyme Immunoassay using a Recombinant Envelope Protein Expressed in Insect Cells for Serological Confirmation of HTLV-I Infection」の研究トピックを掘り下げます。これらがまとまってユニークなフィンガープリントを構成します。

引用スタイル